Who Owns Precigen Stock?
NASDAQ: PGENHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 72.83%
- Held by insiders
- 12.64%
- Institutional holders
- 289
- Institutions 72.8%
- Insiders 12.6%
- Public and other 14.5%
Who owns Precigen stock?
Institutional investors own about 72.8% of Precigen's shares, spread across 289 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 12.64% of PGEN.
The largest institutional holders are Patient Capital Management, LLC (5.34%), Blackrock Inc. (4.81%) and State Street Corporation (3.37%). Together, the top 10 institutions control 25.1% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their PGEN positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PGEN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Patient Capital Management, LLC | 19.04M | 5.34% | +6.8% |
| Blackrock Inc. | 17.15M | 4.81% | +12.6% |
| State Street Corporation | 12.00M | 3.37% | +10.2% |
| Diametric Capital, Lp | 9.27M | 2.60% | +36.3% |
| Vanguard Capital Management LLC | 7.91M | 2.22% | +10.6% |
| Tang Capital Management, LLC | 6.42M | 1.80% | 0.0% |
| Boxer Capital Management, LLC | 5.15M | 1.44% | +47.1% |
| Geode Capital Management, LLC | 5.02M | 1.41% | +8.8% |
| Iridian Asset Management LLC | 4.03M | 1.13% | +12.2% |
| Occam Crest Management LP | 3.61M | 1.01% | -15.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PGEN
| Fund | Shares | % Held |
|---|---|---|
| Advisor Managed Portfolios-Patient Opportunity Trust | 12.90M | 3.62% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 7.48M | 2.10% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.69M | 1.60% |
| iShares Trust-iShares Russell 2000 ETF | 4.93M | 1.38% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.11M | 0.59% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.02M | 0.57% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.80M | 0.50% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.68M | 0.47% |
| First TRT Exch-Trd AlphaDEX Fd.-First TRT Small Cap Growth AlphaDEX Fd | 1.67M | 0.47% |
| iShares Trust-iShares Biotechnology ETF | 1.18M | 0.33% |
Frequently asked questions
Who is the largest shareholder of Precigen?
Patient Capital Management, LLC is the largest institutional shareholder of PGEN, owning 5.34% of shares outstanding (19.04M shares) as of its latest 13F filing.
What percentage of Precigen is owned by institutions?
Institutions own about 72.8% of PGEN shares and 83.4% of the public float.
How much of Precigen do insiders own?
Insiders, such as officers and directors, own about 12.64% of PGEN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.